Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: a double-blind, randomized, placebo-controlled trial.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/24621065
Conclusion of this study
Zinc monotherapy improves mood in overweight or obese subjects most likely through increasing BDNF levels.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study
